We report our studies on spectral sensitivity of meander-type, superconducting NbN thin-film single-photon detectors (SPDs), characterized by GHz counting rates of visible and near-infrared photons and negligible dark counts. Our SPDs exhibit experimentally determined quantum efficiencies ranging from ∼0.2% at the 1.55 μm wavelength to ∼70% at 0.4 μm. Spectral dependences of the detection efficiency (DE) at the 0.4 to 3.0-μm-wavelength range are presented. The exponential character of the DE dependence on wavelength, as well as its dependence versus bias current, is qualitatively explained in terms of superconducting fluctuations in our ultrathin, submicron-width superconducting stripes. The DE values of large-active-area NbN SPDs in the visible range are high enough for modern quantum communications.
We have measured the quantum efficiency (QE), GHz counting rate, jitter, and noise-equivalent power (NEP) of nanostructured NbN superconducting single-photon detectors (SSPDs) in the visible to infrared radiation range. Our 3.5-nm-thick and 100- to 200-nm-wide meander-type devices (total area 10×10μm2), operating at 4.2K, exhibit an experimental QE of up to 20% in the visible range and ∼10% at 1.3 to 1.55μm wavelength and are potentially sensitive up to midinfrared (∼10μm) radiation. The SSPD counting rate was measured to be above 2GHz with jitter <18ps, independent of the wavelength. The devices’ NEP varies from ∼10−17W∕Hz1∕2 for 1.55μm photons to ∼10−20W∕Hz1∕2 for visible radiation. Lowering the SSPD operating temperature to 2.3K significantly enhanced its performance, by increasing the QE to ∼20% and lowering the NEP level to ∼3×10−22W∕Hz1∕2, both measured at 1.26μm wavelength.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.